Submitted by Anonymous (not verified) on 26 July 2024 - 12:12
Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 11, Status: Authorised